Honeywell's clinical manufacturing system implemented at three GSK facilities

Honeywell Industry Solutions, of Brussels, Belgium, has implemented POMS CMS enterprise production management at GlaxoSmithKline's r&d facilities in Tonbridge and Stevenage within the UK, and at the company's product development facility at Upper Providence, Pennsylvania.

GSK has invested $500,000 in POMS CMS to ensure consistent deployment of best business practices across the three sites. The system also supports compliance with 21 CFR Part 11, the FDA regulation that sets standards for electronic record keeping.

'It integrates best practices with quality and regulatory compliance, which enables us to minimise risk, and eliminate unnecessary delays during our chemical development processes,' said Dr. Dermot Moynihan, Senior vice president, chemicals development at GSK.

Using POMS CMS, the company can manage raw materials, intermediates and consumables during product development, ensuring that it controls and uses materials and resources more efficiently. The system supports several key functions, including raw material identification, material receipt and labelling, material status, material issue and return and warehouse management. It also supports reports and queries.

POMS CMS provides complete traceability through all stages of clinical supplies processes, from raw materials to shipment to the investigator and returns. Inventory management and recipe-based interactive electronic batch record capabilities reduce compliance costs and increase material supply efficiency for increasingly complex and frequently changing clinical trials.